je.st
news
Trials of Ebola vaccines begin in Europe and Senegal
2015-07-15 14:49:01| Biotech - Topix.net
Two new Ebola vaccine trials began on Wednesday with volunteers in Britain, France and Senegal getting "prime-boost" immunisations developed by Bavarian Nordic, GlaxoSmithKline and Johnson & Johnson. The mid-stage, or Phase II, trials are designed primarily to test the vaccines' safety, but will also assess whether they provoke an immune response against the deadly virus.
Tags: europe
begin
senegal
trials
Category:Biotechnology and Pharmaceuticals